Double Wood Organic Lion's Mane Mushroom Review

It's the reason it ranks last, and you should understand the trade honestly. The fruiting body is the actual mushroom — the white pom-pom the human trials measured, where the studied beta-glucans and hericenones concentrate. Mycelium is the root-like network grown on a grain substrate (rice or oats), and 'mycelium' products are typically harvested with that grain still attached, so a meaningful fraction of the mass is leftover starch, not mushroom. Double Wood blends both, which dilutes the per-mg bioactive density versus a 100% fruiting-body pick (Real Mushrooms #1, FreshCap #2). It's not worthless — there's real fruiting body in the blend — but on the criterion that actually determines whether you're buying mushroom or grain biomass, a blend sits below the pure-fruiting-body leaders. Defensible at the bulk-budget tier; not equivalent to the top picks.

This is the meaningful verification gap, and it's connected to the blend. Beta-glucans are the specific bioactive fraction the premium picks test for (via an enzymatic assay) and print on the bottle — actual mushroom potency, not grain-starch padding. Double Wood doesn't declare one. The brand does third-party test (heavy metals and microbial panels — the published COA shows no potency assay), which clears the safety bar, but it skips the bioactive-density number. That omission is common in the budget tier precisely because a beta-glucan test would expose how much of a fruiting-body-plus-mycelium blend is actual mushroom versus substrate. So you get verified purity (it's clean) but unverified potency (you don't know the beta-glucan content) — which is the price of the lower-cost bulk bottle.

Yes — it's the genuine strength here and the main reason it's a 'consider' rather than a 'skip.' Double Wood grows and manufactures in the USA and publishes third-party testing for heavy metals and microbial contamination, which clears the contaminant bar that no-COA Amazon brands don't. For a bulk budget bottle, that's a real point in its favor — you're not gambling on an untested import. The honest limit: USA-made and third-party-tested speak to safety and provenance, not to bioactive potency. A clean, well-made fruiting-body-plus-mycelium blend is still a blend, and clean testing doesn't add beta-glucans that the mycelium mass dilutes. Trust the safety; don't read it as potency.

It's a reasonable everyday dose by mass, but it's below the gram-level amounts the human trials used, and the blend makes the comparison softer still. Mori 2009 (PMID 18844328) used 3 g/day of fruiting-body powder for 16 weeks for the cognition signal; Saitsu 2019 (PMID 31413233) used 2.4 g/day — both with confirmed fruiting body. Double Wood's 2-cap serving is 1000 mg of a fruiting-body-plus-mycelium blend, about a third of the Mori dose by mass, and an unknown fraction of that is mycelium-on-grain rather than active mushroom. So the dose is defensible for a daily habit but maps poorly onto the trial protocol, both on quantity and on form. Judge it over 8-12 weeks and keep the evidence base's early stage in mind (2025 systematic review, PMID 40959699, calls it preliminary).

The bulk-quantity buyer who wants the most capsules for the money from a USA-made, third-party-tested brand and accepts that it's a value play, not a potency leader. At 120 caps and the lowest price-per-serving tier on the list, it's a legitimate budget bottle IF you understand the trade: it's a fruiting body + mycelium blend (not the 100% fruiting body the trials measured), and the beta-glucan content is unverified. It's NOT the pick if you want confirmed bioactive density (go Real Mushrooms #1 or FreshCap #2, which test and print beta-glucans), or if the fruiting-body-vs-mycelium issue matters to you (Double Wood's blend sits below the pure picks), or even if you want a confirmed-fruiting-body bottle at a value price without an extract (NOW Foods #5 does that). Buy it as the deliberate bulk-budget play.

1. [1] Mori 2009 PMID 18844328 — Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Double-blind, placebo-controlled trial in 30 adults aged 50-80 with mild cognitive impairment: 3 g/day of fruiting-body powder for 16 weeks significantly improved cognitive-scale scores vs placebo, with gains fading after stopping. The cornerstone cognition trial — and it used confirmed fruiting-body material at 3× Double Wood's dose, the pure form a mycelium blend can't match.
2. [2] Saitsu 2019 PMID 31413233 — Improvement of cognitive functions by oral intake of Hericium erinaceus. Trial in 31 healthy older adults: 2.4 g/day of Hericium erinaceus for 12 weeks significantly improved scores on a standardized Japanese cognitive test. A supporting cognition signal that again used confirmed fruiting-body material at gram-level doses — context for Double Wood's lower 1 g/day blend serving, whose beta-glucan content is unverified.
3. [3] Nagano 2010 PMID 20834180 — Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Placebo-controlled study in 30 women eating Hericium erinaceus for 4 weeks: depression and anxiety measures were significantly lower than placebo. The primary human mood signal — a secondary reason a Lion's Mane bottle is worth a daily run, on a shorter ~4-week timeline than the cognition endpoint.
4. [4] Menon 2025 PMID 40959699 — Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Systematic review of the Hericium erinaceus supplement literature: reports consistent neuroprotective and NGF/BDNF-stimulating signals and cognitive/mood benefits, while concluding the human evidence remains preliminary and calls for larger, longer trials. The honest 'early evidence' frame for any Lion's Mane bottle — and a reminder that a bulk-budget blend doesn't make the underlying case any more certain.